19.100
−1,04%
2026-10-07
Fundamental Analysis
56 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +4.3% | +8.6% | 3 / 3 | +25.0% | -1.23 pp | -0.55 pp | +17.0% | 0.54 | 4.80 | 289 | +25,0% | 8,0 | +4,3% | 4.80 | 5.37 | −10,6% |
| Pts | 0 | 0 | 12 | 12 | 4 | 4 | 8 | 12 | 8 | |||||||
Valuation annotation:Price: 19.100 (close price on 2026-10-07)EPS (TTM): 3.979
Financial charts
1.Revenue & growth
VND bn289Q2/26
1.Revenue & growth
VND bn289Q2/26
2.Profit & growth
VND bn7,98Q2/26
3.Profit mix (Penman)
VND bn37,5Q2/26
4.Margins & cost structure
%8.8%Q2/26
5.Returns & cash cycle
% · days13.1%Q2/26
6.Earnings quality & cash
VND bn56,5Q2/26
7.Asset structure
VND bn421Q2/26
8.Funding & debt health
VND bn · times421Q2/26
9.Revenue backlog
VND bn3,54Q2/26
10.Valuation
times · %4,8×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %1.064Q2/26
Adjusted EPS growth, latest quarter
4.3%
Average adjusted EPS growth, 3 quarters
8.6%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26